Brief: Egetis Q3 Loss Narrows To SEK 22.5 Mln

Egetis Therapeutics AB (publ)

04/11/2021 07:13

Nov 4 (Reuters) - Egetis Therapeutics AB (publ)  EGTX.ST :
    * INTERIM REPORT JANUARY-SEPTEMBER 2021
    * Q3 NET REVENUE MSEK 6.2 (2.6)
    * Q3 QUARTERLY LOSS MSEK -22.5 (-24.7)
    * Q3 CASH FLOW FOR PERIOD MSEK-34.5 (-24.6)

Source text for Eikon:  ID:nMFNc7mYYz 
Further company coverage:  EGTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))